NO20065696L - Piperazinderivater av alkyloksindoler som 5-HT7 reseptoraktive midler. - Google Patents
Piperazinderivater av alkyloksindoler som 5-HT7 reseptoraktive midler.Info
- Publication number
- NO20065696L NO20065696L NO20065696A NO20065696A NO20065696L NO 20065696 L NO20065696 L NO 20065696L NO 20065696 A NO20065696 A NO 20065696A NO 20065696 A NO20065696 A NO 20065696A NO 20065696 L NO20065696 L NO 20065696L
- Authority
- NO
- Norway
- Prior art keywords
- alkyloxindoles
- active agents
- piperazine derivatives
- receptor active
- derivatives
- Prior art date
Links
- 108091005436 5-HT7 receptors Proteins 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- -1 3,3-disubstituted indol-2-one Chemical class 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400956A HU0400956D0 (en) | 2004-05-11 | 2004-05-11 | Pyridine derivatives of alkyl oxindoles |
| HU0500462A HUP0500462A3 (en) | 2005-05-05 | 2005-05-05 | Pyridine derivatives of alkyloxindoles as 5ht7 receptor active agents |
| PCT/HU2005/000047 WO2005108388A1 (en) | 2004-05-11 | 2005-05-10 | Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065696L true NO20065696L (no) | 2007-02-08 |
Family
ID=89985996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20065696A NO20065696L (no) | 2004-05-11 | 2006-12-11 | Piperazinderivater av alkyloksindoler som 5-HT7 reseptoraktive midler. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20070265300A1 (bg) |
| EP (1) | EP1751134A1 (bg) |
| JP (1) | JP2007537225A (bg) |
| KR (1) | KR20070011552A (bg) |
| AU (1) | AU2005240841A1 (bg) |
| BG (1) | BG109767A (bg) |
| CA (1) | CA2565061A1 (bg) |
| CZ (1) | CZ2006769A3 (bg) |
| EA (1) | EA010154B1 (bg) |
| HR (1) | HRP20060402A2 (bg) |
| IL (1) | IL178891A0 (bg) |
| MX (1) | MXPA06012991A (bg) |
| NO (1) | NO20065696L (bg) |
| NZ (1) | NZ551543A (bg) |
| PL (1) | PL381612A1 (bg) |
| RS (1) | RS20060619A (bg) |
| SK (1) | SK51052006A3 (bg) |
| WO (1) | WO2005108388A1 (bg) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
| JP6857651B2 (ja) * | 2015-11-06 | 2021-04-14 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｃｎｓ疾患の処置に有用なインドリン−２−オン誘導体 |
| CN108349942B (zh) * | 2015-11-06 | 2021-03-30 | 豪夫迈·罗氏有限公司 | 用于治疗cns和相关疾病的二氢吲哚-2-酮衍生物 |
| WO2017076842A1 (en) | 2015-11-06 | 2017-05-11 | F. Hoffmann-La Roche Ag | Indolin-2-one derivatives |
| CA3002489C (en) | 2015-11-06 | 2023-11-07 | F.Hoffmann-La Roche Ag | Indolin-2-one derivatives |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
| JP4076234B2 (ja) * | 1996-06-28 | 2008-04-16 | 明治製菓株式会社 | テトラヒドロベンズインドール化合物 |
| WO1998008816A1 (fr) * | 1996-08-26 | 1998-03-05 | Meiji Seika Kaisha, Ltd. | Derives d'indoxyle et psychotropes |
| ZA9711376B (en) * | 1996-12-20 | 1998-07-21 | Lundbeck & Co As H | Indole or dihydroindole derivatives |
| JP4459437B2 (ja) * | 1997-12-25 | 2010-04-28 | 明治製菓株式会社 | テトラヒドロベンズインドール誘導体 |
| JPH11189585A (ja) * | 1997-12-25 | 1999-07-13 | Meiji Seika Kaisha Ltd | ５−ｈｔ７受容体結合能を有するテトラヒドロベンズインドール誘導体 |
| CN1168716C (zh) * | 1998-04-22 | 2004-09-29 | 明治制果株式会社 | 光学活性四氢苯并吲哚衍生物 |
| JP2004231514A (ja) * | 2000-08-31 | 2004-08-19 | Meiji Seika Kaisha Ltd | ５−ｈｔ７受容体結合能を有し、かつ代謝的に安定なテトラヒドロベンズインドール誘導体 |
| AR035521A1 (es) * | 2000-12-22 | 2004-06-02 | Lundbeck & Co As H | Derivados de 3-indolina y composicion farmaceutica que los comprende |
| AU2003257407A1 (en) * | 2002-08-29 | 2004-03-19 | H. Lundbeck A/S | S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof |
| DE602005004024T2 (de) * | 2004-05-11 | 2008-12-24 | EGIS Gyógyszergyár Nyrt | Indol-2-onderivate zur behandlung von erkrankungen des zentralen nervensystems, erkrankungen des magen-darm-trakts und herzkreislauferkankungen |
-
2005
- 2005-05-10 KR KR1020067025137A patent/KR20070011552A/ko not_active Application Discontinuation
- 2005-05-10 EA EA200602081A patent/EA010154B1/ru not_active IP Right Cessation
- 2005-05-10 RS RSP-2006/0619A patent/RS20060619A/sr unknown
- 2005-05-10 SK SK5105-2006A patent/SK51052006A3/sk unknown
- 2005-05-10 CZ CZ20060769A patent/CZ2006769A3/cs unknown
- 2005-05-10 EP EP05745441A patent/EP1751134A1/en not_active Withdrawn
- 2005-05-10 JP JP2007512355A patent/JP2007537225A/ja active Pending
- 2005-05-10 AU AU2005240841A patent/AU2005240841A1/en not_active Abandoned
- 2005-05-10 WO PCT/HU2005/000047 patent/WO2005108388A1/en active Application Filing
- 2005-05-10 NZ NZ551543A patent/NZ551543A/en unknown
- 2005-05-10 CA CA002565061A patent/CA2565061A1/en not_active Abandoned
- 2005-05-10 PL PL381612A patent/PL381612A1/pl not_active Application Discontinuation
- 2005-05-10 US US11/596,472 patent/US20070265300A1/en not_active Abandoned
- 2005-05-10 MX MXPA06012991A patent/MXPA06012991A/es not_active Application Discontinuation
-
2006
- 2006-10-26 IL IL178891A patent/IL178891A0/en unknown
- 2006-11-20 HR HR20060402A patent/HRP20060402A2/xx not_active Application Discontinuation
- 2006-12-11 NO NO20065696A patent/NO20065696L/no not_active Application Discontinuation
- 2006-12-11 BG BG109767A patent/BG109767A/bg unknown
-
2009
- 2009-07-28 US US12/510,872 patent/US20090306144A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007537225A (ja) | 2007-12-20 |
| PL381612A1 (pl) | 2007-06-11 |
| EA010154B1 (ru) | 2008-06-30 |
| BG109767A (bg) | 2008-05-30 |
| AU2005240841A1 (en) | 2005-11-17 |
| HRP20060402A2 (en) | 2007-06-30 |
| EP1751134A1 (en) | 2007-02-14 |
| NZ551543A (en) | 2009-12-24 |
| US20070265300A1 (en) | 2007-11-15 |
| EA200602081A1 (ru) | 2007-04-27 |
| RS20060619A (sr) | 2008-06-05 |
| SK51052006A3 (sk) | 2007-05-03 |
| US20090306144A1 (en) | 2009-12-10 |
| WO2005108388A1 (en) | 2005-11-17 |
| KR20070011552A (ko) | 2007-01-24 |
| IL178891A0 (en) | 2007-03-08 |
| MXPA06012991A (es) | 2007-05-04 |
| CA2565061A1 (en) | 2005-11-17 |
| CZ2006769A3 (cs) | 2007-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
| NO20161634A1 (no) | 3-Z-[1-(4-(N-((4-metyl-piperazin-1-yl)-metylkarbonyl)-N-metyl-amino)-anilino)-1-fenyl-metylen]-6-metoksykarbonyl-2-indolinon, tautomerene, diastereomerene, enantiomerene, blandinger derav og saltene derav, og i kombinasjon med en ytterligere farmakologisk aktiv substans, for anvendelse i forebygging eller behandling av fibrose ved revmatoid artritt | |
| NO20062139L (no) | Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister | |
| NO20080670L (no) | Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister | |
| NO20070855L (no) | Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer. | |
| NO20070336L (no) | Indolderivater som histamin-reseptorantagonister | |
| NO20075406L (no) | Pyrimidindionerivater som prokineticin-2-reseprorantagonister | |
| NO20055219L (no) | Nye forbindelser | |
| NO20066055L (no) | Pyridinderivater | |
| NO20080981L (no) | Nitrocatechol-derivater som COMT-inhibitorer | |
| NO20055977L (no) | Nye benzimidazolderivater | |
| NO20050828L (no) | lndol-3-svovelderivater | |
| NO20021328L (no) | Pyrazolopyrimidier som terapeutiske midler | |
| NO20071137L (no) | Nye piperidinderivater for behandling av depresjon | |
| NO20044763L (no) | 1-(aminoalkyl)-3-sulfonylazaindoler som 5-hydroksytryptamin-6 ligander | |
| NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
| NO20044764L (no) | 1-(aminoalkyl)-3-sulfonylindol og -indazolderivater som 5-hydroksytryptamin-6 ligander | |
| NO20084489L (no) | Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet | |
| NO20060719L (no) | Substituerte cykloalkylaminderivater som modulatorer av kemokin reseptor aktivitet | |
| NO20045589L (no) | Nye forbindelser | |
| NO20060195L (no) | Kinolylamidderivater som CCR-5-antagonister | |
| NO20091590L (no) | Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer | |
| NO20076695L (no) | Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser | |
| NO20080033L (no) | Kinolinderivater som NK3-antagonister | |
| NO20063602L (no) | Benzyl(iden)-laktam-derivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |